A quarterly reagents review is not a paperwork ritual. It is the point at which a laboratory’s purchase history, batch documentation and storage records have to agree with one another, line by line. When a restocked catalogue item arrives carrying a familiar Internal Test Reference, there is a quiet temptation to treat that number as though it were fresh evidence. It is not. For any UK laboratory managing research-use-only materials, understanding exactly what an ITR records — and what it cannot record — is the difference between a defensible review file and a folder of assumptions.
What an Internal Test Reference Actually Records
An ITR is, first and foremost, an indexing device. Research Sciences’ published FAQs on restocks explain that restocked products may carry the same ITR as earlier stock, and that the ITR links to associated sample testing reports. The same guidance is explicit about the limits: an ITR does not confirm that separate deliveries come from the same production lot, and it does not confirm that those deliveries have undergone separate independent testing. That sentence contains the whole argument in miniature. The reference describes a documentation pathway. It says nothing definitive about the physical material in the vial in front of you.
A Certificate of Analysis operates on a different level entirely. Research Sciences describes batch-level analytical verification supporting purity, identity and contaminant screening, with a CoA attached to every product; the FAQs describe HPLC documentation covering purity and identity, while the About page describes full-spectrum testing that includes heavy metals and endotoxin evaluation of submitted samples. The CoA is the document you attach to a receipt line in a review file. The ITR is the document you might use to locate it. Confusing the two inverts the hierarchy of evidence.
Vial labelling reinforces the distinction. The label reference combines the SKU code and expiry date — for example, BPC10-03/27 — and links to the corresponding CoA. Researchers are advised to quote that reference when contacting the shop about documentation, precisely because it points to a specific lot record rather than to a product family. Packaging, by contrast, can vary between deliveries: cap colours are described in the FAQs as not an indicator of identity, analytical quality or manufacturing origin. Neither a shared ITR nor a matching cap tells you what a later delivery actually contains.
The homepage’s headline purity lines, including “≥99% Verified Purity”, are the shop’s published wording at the time of writing and should be reconfirmed on the live site and, more importantly, on the batch CoA supplied with the specific order. Documentation should follow the lot, not the marketing line, and not the restock reference. All of this sits firmly inside in-vitro laboratory work: these materials are not for human or veterinary use, and every documentation decision should reflect that boundary.
Why a Quarterly Review Demands Lot-Level Evidence, Not a Restock Number
Picture a realistic quarterly scenario. A laboratory receives three deliveries of the same catalogue item over three months, perhaps alongside other research materials held under controlled conditions. If the review file records a single ITR against all three receipts, the evidence base collapses into one row. You can no longer demonstrate which CoA belonged to which delivery. You cannot show whether the later delivery was screened for heavy metals and endotoxin under the testing framework the shop describes. You cannot answer a straightforward internal question — “which lot was in use during this assay series?” — without guesswork.
Quarterly reviews exist for exactly these questions. They support reconciliation of receipts against documentation, comparison of HPLC results across lots, consistency checks between label expiry references and use-by planning, and a demonstrable audit trail for internal reviewers, health and safety colleagues and anyone applying COSHH reasoning to storage and disposal. Every one of those tasks is per-lot by nature. An ITR, reused across restocks, is not per-lot. It cannot support trend analysis because it does not identify a trend line; it cannot support traceability because it does not identify a discrete delivery.
There is a second, subtler risk. A shared reference can create an impression of continuity that the underlying record does not support. Two deliveries with the same ITR may share a sample testing report without sharing a production lot, and the FAQ wording is careful on this point. If a documentation query later arises, the review file needs to show that the laboratory checked the batch CoA for the delivery in question, not that it assumed continuity from a reference number.
The homepage lists “CoAs Janoshik Analytical Reports” among its published lines. The practical instruction that follows is simple: open and check the CoA that accompanies the specific batch in hand, and treat the reported content as the shop’s published wording to be reconfirmed on the live site. A restock ITR may still be useful for service correspondence — chasing documentation, confirming a label reference, matching an order to an email thread — but it belongs in a secondary field, never as primary evidence. The distinction is not pedantic; it is the difference between a file that answers questions and one that raises them.
Building a Defensible Quarterly Review File
An evidence ladder for every receipt
Start each receipt line with the catalogue name, SKU, quantity and the label reference printed on the vial. Attach the CoA for that lot directly to the line, then check it against the label reference and the stated product identity before signing off. Record any packaging variation — a different cap colour, for instance — as an observation only, without inferring anything about identity, quality or origin. Keep the ITR as a searchable pointer in a separate column, explicitly labelled as a cross-reference rather than a batch identifier. This structure means a second reviewer can reconstruct the chain from delivery to document to storage without relying on memory.
Storage and handling records belong in the same file
Documentation and physical control should tell the same story. The shop’s handling guidance describes storing lyophilised peptides at −20°C or below, sealed with desiccant and protected from moisture, heat and light, avoiding repeated freeze–thaw cycles, with reconstituted material held at 2–8°C for short-term laboratory use because it is less stable. Where reconstitution is part of an in-vitro workflow, record the diluent volume, the target concentration for the assay and the date prepared. The free reconstitution calculator described on the site is for laboratory research use only and must never be used for human or veterinary dosing. Materials remain not for human or veterinary use, and disposal should follow COSHH and local laboratory safety requirements.
Reordering without erasing history
When reordering from a UK catalogue such as Peptides uk, keep the outgoing lot’s CoA on file so the new delivery can be compared against it rather than substituted by it. If a restock arrives under a shared ITR, ask the shop to confirm the CoA for the current delivery and quote the label reference. The test of any quarterly review is straightforward: could a colleague who has never seen the shelf open the file and trace every vial to a lot, a document and a storage record? A restock reference alone will not pass that test.
